首页> 外文期刊>Diabetes care >Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
【24h】

Efficacy of Fish Oil and/or Probiotic Intervention on the Incidence of Gestational Diabetes Mellitus in an At-Risk Group of Overweight and Obese Women: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial

机译:鱼油和/或益生菌干预对超重和肥胖妇女的患有风险群体妊娠糖尿病发病率的疗效:随机,安慰剂控制,双盲临床试验

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVETo assess whether the risk of gestational diabetes mellitus (GDM) may be lowered and glucose metabolism improved by daily administration of fish oil and/or probiotic supplements in overweight and obese pregnant women.RESEARCH DESIGN AND METHODSWe randomized in a double-blind manner 439 women (mean 13.9 2.1 gestational weeks [gw]) into four intervention groups: fish oil + placebo, probiotics + placebo, fish oil + probiotics, and placebo + placebo. Fish oil (1.9 g docosahexaenoic acid and 0.22 g eicosapentaenoic acid) and probiotic supplements (Lactobacillus rhamnosus HN001 and Bifidobacterium animalis ssp. lactis 420, 10(10) colony-forming units each) were provided for daily consumption from randomization beyond delivery. Primary outcomes were the incidence of GDM diagnosed with oral glucose tolerance test targeted at 24-28 gw and the change in fasting glucose between randomization and late pregnancy (mean 35.2 0.9 gw). Insulin concentration, insulin resistance HOMA2-IR index, and pregnancy outcomes were determined, as were adverse effects related to the intervention. Analyses were by intent to treat.RESULTSNo differences were found among the intervention groups in the maternal and neonatal pregnancy outcomes or side effects related to the intervention (P > 0.05). The proportion of women with GDM (94 of 377; fish oil + placebo, 23 of 96, 24.0%; probiotics + placebo, 25 of 99, 25.3%; fish oil + probiotics, 26 of 91, 28.6%; and placebo + placebo, 20 of 91, 22.0%) and the change in glucose, insulin, or HOMA2-IR (n = 364) did not differ among the intervention groups (P > 0.11 for all comparisons).CONCLUSIONSAn intervention with fish oil and/or probiotics during pregnancy seemed to be both safe and well tolerated but conferred no benefits in lowering the risk of GDM or improving glucose metabolism in overweight and obese women.
机译:ObjectiveTo评估妊娠糖尿病(GDM)的风险是否可以降低和通过每日鱼油和/或益生菌补充剂的超重和肥胖孕妇的益生菌补充剂来改善葡萄糖代谢。用双盲方式随机进行研究设计和方法439女性(平均13.9 2.1妊娠周[GW])分为四种干预群:鱼油+安慰剂,益生菌+安慰剂,鱼油+益生菌和安慰剂+安慰剂。鱼油(1.9克二十二碳酸和0.22g eicosapentaeno酸)和益生菌补充剂(Lactobacillus rhAMnosus HN001和双歧杆菌SSP。乳酸420,10(10)个形成单位,每日消费从随机化超出递送。主要结果是诊断出靶向24-28 GW的口服葡萄糖耐量试验的GDM的发病率,随机化和晚期妊娠之间的空腹葡萄糖的变化(平均35.2 0.9 GW)。确定胰岛素浓度,胰岛素抵抗HOMA2-IR指数和妊娠结果,与干预有关的不利影响。分析意图旨在治疗妇幼的孕妇和新生儿妊娠结果或与干预相关的副作用中的干预群中发现了差异(P> 0.05)。 GDM的妇女比例(377个中的94个;鱼油+安慰剂,23个,共96例,24.0%;益生菌+安慰剂,25个,共99个,25.3%;鱼油+益生菌,26个,共91例,28.6%;和安慰剂+安慰剂,91,22.0%的20%,葡萄糖,胰岛素或HOMA2-IR(n = 364)的变化在干预组中没有差异(所有比较P> 0.11)。与鱼油和/或益生菌的干预均干预在怀孕期间似乎都是安全且耐受性,但赋予降低GDM或改善超重和肥胖女性的葡萄糖代谢的风险没有益处。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号